Mazdutide

Inquire / Price
  • Model Number:
    RL392025071601
  • Brand Name:
    信尔美®
  • Origin:
    Original invention from China
  • Small Orders:
    Small batches also available
  • Tags:
Inquire Now Link

Poster
  • Details
  • Description
  • Packaging Size
    2vail/Box&4vail/Box
  • Strength
    2mg&4mg&6mg
  • Compositon
    Mazdutide
  • Treatment
    Chronic Weight Management: Obesity and Overweight
  • Form
    Injection / Autoinjection Pen
  • Brand
    信尔美®
  • Quantity Unit
    2mg*2vail/Box&4mg*2vail/Box&6mg*2vail/Box
  • Manufacturer
    Innovent Biologics,china

About Mazdutide (IBI362)

Mazdutide , a GLP-1R and GCGR dual agonist, in China. As a mammalian oxyntomodulin (OXM) analogue, mazdutide may offer additional benefits beyond those of GLP-1 receptor agonists—such as promoting insulin secretion, lowering blood glucose and reducing body weight—by also activating the glucagon receptor to increase energy expenditure and improve hepatic fat metabolism. Mazdutide has demonstrated excellent weight loss and glucose-lowering effects in clinical studies. It has also shown benefits in reducing waist circumference, blood lipids, blood pressure, blood uric acid, liver enzymes, and liver fat content, as well as improving insulin sensitivity.

  • Mazdutide sold under the brand name 信尔美® in china.

<Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight>

<Innovent Announces Mazdutide, First Dual GCG/GLP-1 Receptor Agonist, Received Approval from China's NMPA for Chronic Weight Management >

Mazdutide is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial Body Mass Index (BMI) of:

  • BMI ≥ 28 kg/m² (obesity); or
  • BMI ≥ 24 kg/m² (overweight) in the presence of at least one weight-related comorbid condition (e.g., hyperglycemia, hypertension, dyslipidemia, fatty liver, or obstructive sleep apnea syndrome and etc.).

Mazdutide is injected once a week。


Link

Poster

Top